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Abstract
Background: In the developing brain, self-renewing neural stem/progenitor cells (NSPC) give rise to neuronal and
glial lineages. NSPC survival and differentiation can be altered by neurotropic viruses and by the anti-viral immune
response. Several neurotropic viruses specifically target and infect NSPCs, in addition to inducing neuronal loss,
which makes it difficult to distinguish between effects on NSPCs that are due to direct viral infection or due to the
anti-viral immune response.
Methods: We have investigated the impact of anti-viral immunity on NSPCs in measles virus (MV)-infected
neonates. A neuron-restricted viral infection model was used, where NSPCs remain uninfected. Thus, an anti-viral
immune response was induced without the confounding issue of NSPC infection. Two-transgenic mouse lines were
used: CD46+ mice express the human isoform of CD46, the MV entry receptor, under the control of the
neuron-specific enolase promoter; CD46+/IFNγ-KO mice lack the key anti-viral cytokine IFNγ. Multi-color flow
cytometry and Western Blot analysis were used to quantify effects on NSPC, neuronal, and glial cell number, and
quantify effects on IFNγ-mediated signaling and cell markers, respectively.
Results: Flow cytometric analysis revealed that NSPCs were reduced in CD46+/IFNγ-KO mice at 3, 7, and 10 days
post-infection (dpi), but were unaffected in CD46+ mice. Early neurons showed the greatest cell loss at 7 dpi in
both genotypes, with no effect on mature neurons and glial cells. Thus, IFNγ protected against NSPC loss, but did
not protect young neurons. Western Blot analyses on hippocampal explants showed reduced nestin expression in
the absence of IFNγ, and reduced doublecortin and βIII-tubulin in both genotypes. Phosphorylation of STAT1 and
STAT2 occurred independently of IFNγ in the hippocampus, albeit with distinct regulation of activation.
Conclusions: This is the first study to demonstrate bystander effects of anti-viral immunity on NSPC function. Our
results show IFNγ protects the NSPC population during a neonatal viral CNS infection. Significant loss of NSPCs in
CD46+/IFNγ-KO neonates suggests that the adaptive immune response is detrimental to NSPCs in the absence of
IFNγ. These results reveal the importance and contribution of the anti-viral immune response to neuropathology
and may be relevant to other neuroinflammatory conditions.
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Background
Central nervous system (CNS) viral infections during fetal
and postnatal periods significantly alter neurodevelop-
ment, leading to long-term cognitive deficits, blindness,
hearing loss, and neurological disease [1–4]. Neurotropic
viruses cause CNS damage by directly infecting and killing
resident CNS cells (polio virus, Semliki Forest virus) and/
or by inducing an immune response that causes inflam-
mation and encephalitis (measles virus, human immuno-
deficiency virus, cytomegalovirus, herpes simplex virus,
West Nile virus) [5–10]. Ideally, the anti-viral immune re-
sponse must carefully control a viral infection with min-
imal damage to non-renewable neurons. An excessive or
prolonged inflammatory response can lead to bystander-
induced damage and can contribute to neuropathology
[11, 12].
In the developing CNS, self-renewing neural stem pre-
cursor cells (NSPC) provide a pool of progenitor cells
that can mature into functional neurons or glia [13].
Neuronal loss is a common pathological outcome of
CNS infections, but effects on NSPC function may also
contribute to viral-induced neuronal loss. Neurotropic
viruses can disrupt the survival, proliferation, and matur-
ation of NSPCs, which ultimately impairs neurogenesis.
Lack of CNS repair may be caused by a deficit in the
NSPCs pool, disrupted formation of new neurons from
NSPCs, or changes in cell fate. Furthermore, some vi-
ruses specifically target NSPCs [14, 15]. Many studies
that measured NSPC survival and differentiation during
viral infections have done so with viruses that infect and
replicate in NSPCs [16–18]. This makes it experimen-
tally difficult to distinguish between which component
contributes to neuropathology: primary viral infection or
bystander inflammation.
The immune response in the CNS can non-cytolytically
control viral replication and spread via anti-viral cytokines.
IFNγ is a pro-inflammatory cytokine produced by activated
natural killer (NK) cells, natural killer T-cells (NKT), and
T-cells and are required for non-cytolytic control of mea-
sles virus [19–21] and other neurotropic viruses [22–26].
During the anti-viral immune response, the release of pro-
and anti- inflammatory cytokines also influences NSPC sur-
vival and neurogenesis [27, 28]. There is conflicting evi-
dence as to whether IFNγ is pro-neurogenic [29–32] or
anti-neurogenic [33–37], depending on the age studied
(neonate or adult), model system, and the presence or ab-
sence of the inflammatory response. Moreover, there is
conflicting evidence as to whether IFNγ induces apoptosis
in neural cells, as human oligodendrocyte precursors are
killed by IFNγ, but primary neurons are protected from
other neurotoxic insults by IFNγ signaling [38, 39].
We hypothesized that IFNγ protects neonatal NSPCs
during a CNS viral infection. To evaluate the effects of the
anti-viral immune response on NSPCs and determine if
loss of IFNγ alters these effects, a transgenic mouse model
of neuron-restricted measles virus (MV) infection was
used. NSE-CD46+ mice express the human isoform of
CD46, a receptor by which MV binds and enters cells. In
this model, CD46 expression is driven by the neuron-
specific enolase (NSE) promoter, restricting human CD46
expression and MV infection to mature CNS neurons
[40]. In order to study the role of IFNγ, we also use CD46
+ mice that have been backcrossed to IFNγ-KO mice
(CD46+/IFNγ-KO). Thus, modulations in NSPC function
during MV infection can be examined with or without the
contribution of IFNγ. Importantly, NSE is not expressed
by NSPCs that express nestin [41], which spares NSPCs
from MV infection in our model. Therefore, we are able
to study the impact of the anti-viral immune response on
NSPCs, without the confounding issue of direct viral in-
fection of these cells.
Our study focuses on the fate of NSPCs that remain un-
infected during a neonatal viral infection. Using the NSE-
CD46+ model, we evaluated the bystander effects of the
anti-viral immune response on NSPC function. Multi-
color flow cytometry was used to quantify effects on the
number of NSPCs, on cells specified to the neuronal
lineage, and on cells specified to the glial lineage in vivo.
We observed significant NSPC loss in MV-infected CD46
+/IFNγ-KO pups at 7 and 10 dpi, but not in the infected
CD46+ pups, suggesting that IFNγ protects NSPCs during
a neuroinflammatory response. However, early neuronal
cells were not protected; MV-infected CD46+ and CD46
+/IFNγ-KO pups both displayed loss of early neurons and
a decrease in neurogenesis. Furthermore, mature neurons
and cells specified to the glial lineage were unaffected dur-
ing the course of infection. Signal transducers and activa-
tors of transcription-1 (STAT1), a key downstream signal
transducer for IFNγ, was phosphorylated in hippocampal
explants from both CD46+ and CD46+/IFNγ-KO pups,
suggesting that other cytokines in the inflammatory re-
sponse were contributing to STAT activity in the absence
of IFNγ. These results are the first to indicate that IFNγ
protects NSPCs during a neonatal viral infection and fur-
thers our understanding of what cell types are susceptible
to the effects of the anti-viral immune response.
Methods
Animals
NSE-CD46+ and NSE-CD46+/IFNγ-KO transgenic mice
were provided by Glenn Rall (Fox Chase Cancer Center)
[19, 40]. Animal use protocols (#1408-10) were reviewed
and approved by the Duquesne University Animal Care
and Use Committee.
Measles virus and BrdU injections
MV-Edmonston was purchased from American Type
Culture Collection (ATCC) and passaged and titred in
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Vero cells. On postnatal day 2 (P2), pups were intracere-
brally injected with measles virus (104 PFU in a 10 μl vol-
ume) using a 1 cc syringe (BD Biosciences) and 271/2G
needle (BD Biosciences). Control pups were injected with
an equal volume of media from mock-infected Vero cells.
Twenty-four hours prior to being sacrificed on the indi-
cated day post-infection (dpi), control and MV-infected
mice were injected intraperitoneally with 50 μg/g 5-
bromo-2′-deoxyuridine (BrdU; BD Biosciences), using a
1-cc syringe and 30G x ½-in needle (BD Biosciences).
Dissociation of whole-brain tissue and flow cytometric
analysis
Mice were anesthetized with isoflurane, and entire
brains were removed from control and MV-infected ne-
onates on 3, 7, and 10 dpi. Whole-brain tissue was proc-
essed into single-cell isolates and labeled as described
[17, 42], with modifications. Briefly, brain samples were
dissociated into single-cell suspensions following incuba-
tion with TrypLE Select (Life Technologies)/200 U/ml
DNaseI (Roche)/1 mM MgCl2 (Life Technologies). Cell
suspensions were filtered through 70 μm and 40 μm cell
strainers (Fisher Scientific) and counted by trypan blue ex-
clusion. Further, 106 cells were labeled using the FITC BrdU
Flow Kit (BD Biosciences) and the following antibodies:
APC-A2B5 (1:10; Miltenyi Biotec), PE-CD24 (1:50; BD Bio-
sciences), FITC BrdU (1:50; BD Biosciences), PE-Nestin
(1:10; R&D Systems), FITC-NeuN (1:50; Millipore), rabbit
anti-doublecortin (DCX, 1:50; Santa Cruz Biotechnology
Inc) and secondary fluorescent-conjugated goat anti-rabbit
IgG-PE (1:100; eBioscience), rabbit anti-GFAP (1:250;
Dako), and goat anti-rabbit IgG-PE (1:100; eBioscience) sec-
ondary. Labeling with cell surface markers (A2B5, CD24)
was performed before fixation and permeabilization.
Cells were analyzed the same day on a BD Accuri™ C6
flow cytometer (BD Biosciences). For each brain sample,
250,000 events were run for analysis. Dead cells and debris
were excluded based on 7-AAD (BD Biosciences) staining
as described [43, 44] (Additional file 1: Figure S1). Posi-
tively and negatively labeled cell populations and gating
parameters were based on unlabeled and isotype control-
labeled cells.
Immunohistochemical analysis of brain tissue
Control and MV-infected mice were anesthetized with
isoflurane and perfused with 4 % paraformaldehyde/PBS.
Fixed brains were sliced along the midline and cryopro-
tected in a 30 % sucrose/PBS solution at 4 °C. Brains
were immersed in tissue embedding compound (Fisher)
and frozen in a dry ice/isopentane bath. Sagittal cryosec-
tions (16 μM) were cut on the cryostat (Microm
HM550, Thermo Scientific) and stored at −80 °C until
staining. Antigen retrieval was performed by heating the
tissue for 30 min at 80 °C in a 10-mM sodium citrate
solution. Standard immunohistochemistry was per-
formed to detect MV-infected cells (mouse anti-matrix
protein and mouse anti-hemagglutinin, 1:400; Millipore),
neural stem/progenitor cells (chicken anti-nestin for co-
labeling with MV (1:200; Novus Biologicals) or mouse
anti-nestin for co-labeling with NeuN (1:400; Millipore)),
and mature neurons (NeuN (guinea pig anti-NeuN)
1:500; Millipore). Sections were incubated with the pri-
mary antibody overnight at 4 °C in 4 % goat serum/PBS.
Then, the slides were washed ×3 with PBS and incubated
with the secondary antibody (goat anti-guinea pig-488,
donkey anti-mouse-555, and goat anti-chicken-488; all
at 1:000 from Thermo-Fisher) and Hoechst33342 stain
(Molecular Probes) for 1 h at 25 °C. For all histological
analyses, at least three sagittal sections per brain were
examined, and at least four mice per experimental group
were assessed.
Apoptosis in MV-infected brain tissue
Brains from control and MV-infected mice (7 dpi) were
collected following the procedure for the immunofluor-
escence assay. Sagittal brain sections were fixed in 3.7 %
formaldehyde and subjected to terminal deoxynucleoti-
dyl transferase dUTP nick end labeling (TUNEL; (TdT-
FragEL DNA fragmentation detection kit; Millipore)
using diaminobenzidine as a substrate. For counting of
TUNEL-positive cells, four non-overlapping fields (×20)
were chosen by a blinded examiner moving dorsally to
ventrally across the slice. TUNEL-positive cells were
counted on an Olympus BX41 Laboratory Microscope
(Olympus Corporation). Three sagittal slices were
counted from each brain, with three mice assayed per
condition. The average number of TUNEL-positive cells
per ×20 field ± standard error was determined.
Western Blot analysis on hippocampal explants
Samples were processed and analyzed as described [45,
46], with modifications. For samples used for analysis of
phosphorylated proteins, pups were perfused with
10 mM sodium fluoride in ice cold ×1 PBS prior to brain
dissection in order to inactivate phosphatases [47]. The
right and left hippocampus were dissected from each
animal [48] and explants were combined, weighed, and
sonicated in ×1 cell lysis buffer (Cell Signaling Tech-
nologies) supplemented with Protease Inhibitor Cocktail
(Sigma). Samples were sonicated for 5–10 pulses for 1–2
s each (Misonix Inc. Model XL2020). The total protein
content of cell lysates was quantified using the Pierce®
BCA Protein Assay Kit (ThermoScientific) and the 1420
Multilabel Counter Victor3 plate reader (Perkin Elmer).
Twenty micrograms of total protein was loaded for all
proteins but STAT2 and STAT2-P (40 μg was loaded).
Proteins were separated on NuPAGE 7 % Tris-Acetate
(Nestin, STAT1, STAT1-P, STAT2, STAT2-P, STAT3,
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STAT3-P; Invitrogen) or NuPAGE 10 % Bis-Tris (GFAP,
DCX, βIII-tubulin; Invitrogen) gels and semi-dry trans-
ferred (BioRad TransBlot Semi-Transfer Cell) to
immobilon-FL membranes (Millipore). Membranes were
incubated in 50 % odyssey blocking buffer (LI-COR Bio-
sciences) in 0.1 % PBS/Tween (PBS/Tw; Sigma) for
30 min at room temperature, washed in PBS/Tw and in-
cubated in the following primary antibodies, diluted in
blocking solution, overnight at 4 °C on a shaker: mouse
anti-nestin (1:250; Millipore), rabbit anti-DCX (1:1,000;
Abcam), rabbit anti-βIII-tubulin (1:1,000; Cell Signaling
Technologies), rabbit anti-GFAP (1:1,000; Dako), rabbit
anti-STAT1 (1:1,000; BD Biosciences), mouse anti-
STAT1-P (1:1,000; BD Biosciences), rabbit anti-STAT2
(1:1,000; Millipore), rabbit anti-STAT2-P (1:500; Milli-
pore), mouse anti-STAT3 (1:2500; BD Biosciences),
rabbit anti-STAT3-P (1:1,000; Cell Signaling Technolo-
gies), mouse anti-GAPDH (1:10,000; Millipore), and
rabbit anti-GAPDH (1:3,000; Cell Signaling Technolo-
gies). Membranes were washed three times in PBS/Tw,
incubated with secondary antibodies (infrared 800 or
700 nm anti-rabbit or anti-mouse 1:10,000; LI-COR Bio-
sciences) diluted in blocking solution, for 1 h at room
temperature and washed again in PBS/Tw. Membranes
were imaged and quantified with the Odyssey® Infrared
Imager (LI-COR Biosciences). Protein levels were nor-
malized to GAPDH as a protein loading control.
Statistical Analysis
Data are presented as the mean ± standard error (SE).
Means represent data from a minimum of three independ-
ent experiments of 3–6 neonates for flow cytometry ex-
periments and a minimum of four hippocampal explants
for Western Blot experiments. Comparisons between con-
trol and MV-infected experimental groups in flow cytom-
etry experiments were performed by three-way ANOVA
followed by a Tukey’s multiple-comparison test, using
SPSS statistics (IBM). Comparisons made in TUNEL as-
says and Western Blot experiments were performed by
two-way ANOVA followed by a Tukey’s multiple-
comparison test using GraphPad Software (GraphPad,
Inc.). A p value of less than 0.05 was considered statisti-
cally significant.
Results
IFNγ protects neural stem/progenitor cells (NSPCs), but
not early neurons, during viral infection of the neonatal
brain
We first confirmed that MV infection is limited to CNS
neurons in CD46+ neonates. Previous studies have dem-
onstrated that MV antigen co-localizes with neuronal
markers, but co-localization with markers for NSPCs (nes-
tin) has not been investigated previously. MV+ cells were
noted in the thalamus, hippocampus, and cerebellum early
in infection (3 days post-infection (dpi); data not shown),
with subsequent MV spread in the cerebral cortex at other
time points (7–10 dpi, Fig. 1). Nestin+ cells were found in
the vicinity of MV+ cells in multiple brain regions (Fig. 1,
a–i); however, nestin and MV staining did not co-localize
in any cells. Markers for mature neurons (NeuN, J-L)
showed nuclear staining of MV+ cells, demonstrating that
MV infection is limited to mature neurons.
We investigated whether a lack of IFNγ might impact
the proportion of NSPCs or cells specified to the neur-
onal lineage during the course of infection. CD46+ and
CD46+/IFNγ-KO pups were mock or MV-infected on
postnatal day 2 (P2) and whole brains were harvested at
3, 7, or 10 days post-infection (dpi). The study endpoints
reflect different phases of disease progression and cor-
respond to when the specific arms of the immune sys-
tem are active in the CD46+ model in both adults and
neonates (unpublished observations and [49]). Three dpi
corresponds to the initial phase of infection when the in-
nate immune response predominates, including infiltra-
tion of IFNγ-producing natural killer (NK) cells. This is
also the first day of detectable MV antigen and T-cell in-
filtration in the CNS [49]. At 7 dpi, the adaptive immune
response predominates with peak infiltration of IFNγ-
producing T-cells [49, 50]. Peak T-cell infiltration con-
tinues until 10 dpi, when severe signs of clinical disease
and death occur in neonates.
Cell isolates from whole brains were labeled with
markers for multipotent neural stem/progenitor cells (nes-
tin), immature neurons (CD24, doublecortin (DCX)), and
mature neurons (NeuN), and multi-color flow cytometry
was used to quantify the percentage of positively labeled
cells. We observed an age-dependent decrease in the per-
centage of NSPCs (A, E) and early neurons (B, C, F, G),
and an age-dependent increase in NeuN+ mature neurons
(D, H) in both CD46+ and CD46+/IFNγ-KO genotypes
(Fig. 2). Therefore, the percentage of positively labeled
cells was compared between control and MV-infected
brains at each dpi within each mouse genotype.
Overall, we observed significantly greater NSPC and im-
mature neuron cell loss in MV-infected pups that lack
IFNγ (CD46+/IFNγ-KO; Fig. 2e–g) compared to CD46+
pups (Fig. 2a–c) by three-way ANOVA (p < 0.001). The
percentage of nestin + cells was reduced at 3 dpi, the first
day of detectable MV antigen and T-cell infiltration in the
CNS, and was significantly decreased at 7 and 10 dpi
(Fig. 2e) in CD46+/IFNγ-KO pups, when the adaptive im-
mune response and T-cell infiltration peak [49]. In con-
trast, nestin+ cells were maintained at all dpi in CD46+
mice in comparison to mock-infected mice (Fig. 2a), sug-
gesting that IFNγ preserves this population during a CNS
viral infection.
CD24+ and DCX+ immature neurons were most vul-
nerable to cell loss in CD46+ MV-infected brains at 7 and
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10 dpi (Fig. 2b, c), but were lost at all dpi in MV-infected
IFNγ-KO mice (Fig. 2f, g). Furthermore, the reduction in
the percentage of CD24+ and DCX+ cells at 7 dpi was
nearly twofold greater in CD46+/IFNγ-KO pups com-
pared to CD46+ pups. When the percent change in posi-
tively labeled cells was compared between control and
MV-infected animals at 7 dpi, IFNγ-KO mice displayed a
53 and 37 % decrease in CD24+ and DCX+ cells, respect-
ively (Fig. 2f, g), compared to CD46+ mice (CD24+ 22 %;
DCX+ 20 %; Fig. 2b, c). Conversely, there was no signifi-
cant difference in the percentage of NeuN+ mature neu-
rons, between control and MV-infected brains at all dpi,
in both genotypes (Fig. 2d, h). From these results, we sus-
pect that the anti-viral immune response is detrimental to
NSPCs and that IFNγ may be protective against the detri-
mental effects of the immune response for NSPCs during
a neonatal viral infection.
Loss of IFNγ does not alter glial differentiation
CNS viral infections are often associated with increased
glial activation and/or impaired glial function. Manchester
et al. [50] reported widespread glial activation and astro-
cytic GFAP staining in MV-infected NSE-CD46+ pups at
7 dpi, leading us to speculate that the reduction in NSPC
and neuronal cell number may be attributed to NSPCs be-
ing specified to the glial lineage and adopting a glial cell
fate in MV-infected brains. Additionally, microglia and as-
















Fig. 1 MV infects neurons, but not NSPCs, in CD46+ mice. Sagittal brain sections from MV-infected CD46+ mice were collected at 10 days post-
infection (dpi) and stained for MV (red) and nestin (green; a–i) or MV (red) and NeuN (green; j–l). All sections were stained with Hoechst (blue) to
visualize nuclei. Representative images are shown from different brain regions, including the thalamus (a–c), CA1 region of the hippocampus
(d–f), fiber tracts of the medial forebrain bundle system (g–i), and the dentate gyrus (j–l). MV staining was restricted to NeuN+ cells (j–l).
Co-localization with nestin and MV was not observed in any brain region (a–i). Panels a–i: Magnification = ×20; scale bar = 50 μm. Panels j–l:
Magnification = ×40; scale bar = 25 μm
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IFNγ-dependent effects on glial function [11, 51]. We
evaluated whether the anti-viral immune response and a
lack of IFNγ impacted glial cell number. Cell isolates from
mock- and MV-infected brains were labeled with A2B5,
O4, or GFAP, and flow cytometry was used to quantify the
percentage of glial precursors, oligodendrocytes, and as-
trocytes, respectively. Overall, glial cell number between
control and MV-infected brains from CD46+ (Fig. 3a–c)
and CD46+/IFNγ-KO (Fig. 3e–g) pups was unaffected at
all dpi examined. Age-related differences in A2B5+ glial
precursors (Fig. 3a) and O4+ oligodendrocytes (Fig. 3b, f )
were observed in the presence and absence of the virus.
Unexpectedly, we did not observe a significant effect on
the percentage of GFAP+ cells (Fig. 3c, g) nor on the ex-
pression level of GFAP (Fig. 3d, h; MFI: Mean Fluorescent
Intensity) between control and MV-infected pups in both
types of mice, suggesting that there was minimal reactive
gliosis in the whole brain. From these results, we con-
cluded that the reduction in NSPC and early neuronal cell
number was not due to NSPCs adopting a glial cell fate
and next considered whether the loss of NSPCs and early
neurons was due to effects on cell proliferation and/or ab-
errant neuronal differentiation.
MV infection and loss of IFNγ do not alter BrdU uptake
by nestin+ cells
IFNγ has been shown to either promote or inhibit NSPC
proliferation and can regulate neurogenesis [30, 31, 33,
34, 36, 52–55]. One mechanism by which IFNγ may pre-
serve the NSPC pool in CD46+ mice is by promoting
NSPC proliferation. Similarly, the loss of early neurons
may be attributed to either a lack of early neuron/neuro-
blast proliferation and/or impaired neuronal differenti-
ation. We characterized the effects of MV infection and
loss of IFNγ on the proliferation of nestin+, CD24+, and
DCX+ cells, by isolating cells from pups that were
injected with BrdU 24 h prior to harvest to label actively
dividing cells. The proportion of BrdU+ cells within each
cell population was quantified by flow cytometry.
Reduced BrdU uptake was observed in MV-infected
CD46+/IFNγ-KO pups at 3 and 7 dpi compared to
uninfected mice (Fig. 4d) and CD46+ pups at the
same time points (Fig. 4a). However, the %BrdU+
cells within the nestin+ cell population showed no
significant difference between control and MV-
infected pups in both genotypes (Fig. 4b, e), suggest-
ing that the loss of nestin+ cells in CD46+/IFNγ-KO
Fig. 2 IFNγ preserves the NSPC population, but not early neurons. CD46+ (a–d) and CD46+/IFNγ-KO (e–h) control and MV-infected neonatal
whole-brain isolates labeled for multipotent NSPCs (nestin: a, e) and cells specified to the neuronal lineage (CD24: b, f; DCX: c, g; NeuN: d, h), at
3, 7, and 10 dpi. The percentage of nestin + cells was significantly reduced at 7 and 10 dpi in MV-infected IFNγ-KO (e), but not MV-infected CD46
+ mice (a). Significant CD24+ (b, f) and DCX+ (c, g) immature neuron cell loss occurred in both genotypes. Mature NeuN+ cell number was
unaffected (d, h). *p < 0.01 significantly different uninfected versus MV-infected; #p < 0.05 significantly different between dpi
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mice (Fig. 4e) is not due to impaired proliferation of
the NSPC pool.
To evaluate whether neuronal differentiation was af-
fected, we quantified the percentage of BrdU+ cells
within the early neuronal CD24+ (Fig. 4c, f ) and DCX+
populations (not shown). We were unable to detect
BrdU-DCX double-positive cells by flow cytometry, sug-
gesting that either the DCX+ cell population is too small
in number to detect a small fraction of the cells that
may have taken up BrdU (less than 3 % of cell isolate is
DCX+; Fig. 2c, g) or that this population is more mature
than the CD24+ population and that fewer DCX+ cells
are proliferating at the time points examined. BrdU up-
take was significantly reduced within the CD24+ popula-
tion at 10 dpi in MV-infected CD46+ (Fig. 4c) and CD46
+/IFNγ-KO mice (Fig. 4f ), corresponding to when severe
signs of illness and morbidity occur in this model.
These results suggest that IFNγ does not directly
maintain the NSPC population through enhanced prolif-
eration and that the loss of nestin+ cells in CD46
+/IFNγ-KO mice is not due to impaired proliferation.
Additionally, it is unlikely that the reduction in nestin+
cells is due to NSPCs being promoted to the neuronal
lineage, as CD24+ and DCX+ populations are reduced
and not increased, as would be expected with NSPCs
adopting a neuronal cell fate.
MV infection induces widespread apoptosis in brain
tissue
IFNγ may protect against toxic insults or induce apop-
tosis, depending on the type of neural cell [36, 38]. If
IFNγ contributed to protection of NSPCs in the CD46+
model, then we would predict greater apoptosis in CD46
+/IFNγ-KO mice during infection. To test whether IFNγ
was associated with less apoptosis, we performed
TUNEL stains on brain tissue from MV-infected mice (7
dpi). Significant TUNEL reactivity was found throughout
the brains of MV-infected mice in comparison to unin-
fected controls (Fig. 5 a–c). No significant differences
were found between CD46+ and CD46+/IFNγ-KO mice,
suggesting that IFNγ does not reduce the number of
cells undergoing apoptosis across the whole brain. We
further examined brain tissue for staining of NeuN (ma-
ture neurons; green) and nestin (NSPCs, red) to assess if
differences in neuronal health could be observed. Over-
all, we did not observe changes in the morphology of
Fig. 3 IFNγ does not alter glial differentiation. CD46+ (a–d) and CD46+/IFNγ-KO (e-h) control and MV-infected neonatal whole-brain isolates were
labeled for early glial precursors (A2B5: a, e), oligodendrocytes (O4: b, f) and astrocytes (GFAP: c, g). The average GFAP mean fluorescent intensity
(MFI) was quantified and normalized to the MFI of the isotype control (d, h). There was no significant difference between control and MV-
infected pups for the glial cell populations in either genotype. A significant decrease in %A2B5+ cells was observed in CD46+ (a), but not IFNγ-
KO mice (d) mice from 3 to 10 dpi and a significant increase in O4+ oligodendrocytes was observed from 3 to 10 dpi in both genotypes (b, e).
Age-dependent differences in GFAP expression also occurred (d, h). *p < 0.01 significantly different uninfected versus MV-infected; #p < 0.05
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the hippocampal formation (Fig. 5 d–g) or cortex (not
shown). These results demonstrate that although apop-
tosis is seen throughout the brain during infection, the
level of cell death is not sufficient to cause marked
changes in the structure of the brain.
IFNγ preserves NSPC, but not neuronal, markers within
the hippocampus during infection
Immunohistochemical staining for MV matrix and nu-
cleocapsid proteins showed widespread MV-infection at 7
dpi (not shown) that was restricted to neuronal cell bodies
and axonal processes. Although the infection was wide-
spread, the hippocampus and surrounding area consist-
ently displayed a “hot-spot” or focal area of MV-infected
neurons at later dpi, compared to other brain regions, as
has been noted previously [40]. As well, an increase in
TUNEL+ apoptotic cells in the dentate gyrus of the hippo-
campus was reported at 7 dpi [50], suggesting that in
addition to being a neurogenic region rich in NSPCs, the
hippocampus is susceptible to the effects of and negatively
impacted by MV infection. To evaluate effects on various
cell types within the hippocampus, we attempted to isolate
cells from neonatal hippocampal explants, but due to
technical limitations we were unable to isolate enough
cells for cell labeling and flow cytometry. Instead, we
performed Western Blot analysis on neonatal hippocam-
pal explants in order to evaluate changes in cell marker
protein levels.
Changes in protein level in the hippocampus reflected
changes in cell numbers that were measured by flow cy-
tometry for NSPCs and immature neurons. MV-infected
CD46+/IFNγ-KO explants displayed significantly lower
nestin expression (Fig. 6e) compared to MV-infected
CD46+ mice (Fig. 4a), which displayed no change with
infection. Furthermore, there was a significant reduction
in DCX protein at 7 dpi, not 3 dpi, in CD46+ pups
(Fig. 6b), whereas DCX levels were reduced at all time
points in CD46+/IFNγ-KO mice (Fig. 6f ). βIII-tubulin
levels were higher at 7 dpi compared to 3 dpi in both ge-
notypes consistent with continued maturation of neu-
rons; however, a significant decrease in βIII-tubulin was
observed at 7 dpi in MV-infected explants, suggesting
that the viral infection is detrimental to mature neurons,
in addition to NSPCs (Nestin; Fig. 2a, e) and young neu-
rons (DCX; Fig. 2b, f ), in the hippocampus. The βIII-
tubulin results contrast that observed for %NeuN+ cells
quantified by flow cytometry (Fig. 2d, h), where no effect
on mature neuron cell number was observed across the
whole brain. GFAP levels were elevated significantly with
infection in CD46+ mice, but not in CD46+/IFNγ-KO
Fig. 4 MV infection does not alter BrdU uptake by NSPCs. CD46+ (a-c) and CD46+/IFNγ-KO (d-f) pups were injected with BrdU 24 h before
whole-brain isolates were processed and labeled for BrdU+ cells (a, d), or BrdU(+)Nestin(+) (b, e), and BrdU(+)CD24(+) (c, f) double-positive cells.
Reduced BrdU uptake was observed in MV-infected CD46+/IFNγ-KO pups at 3 and 7 dpi (d), but not CD46+ mice (a). BrdU+ cells within the
Nestin+ population showed no significant difference between control and MV-infected pups in both genotypes, but a significant reduction with
age (b, e). The percentage of BrdU+ cells within the CD24+ cell population was reduced at 10 dpi (c, f), when severe illness and death occurs. *p
< 0.01 significantly different uninfected versus MV-infected; #p < 0.05 significantly different between dpi
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mice, in comparison to uninfected controls at 7 dpi, sug-
gesting that localized reactive astrogliosis may be occur-
ring in the hippocampus in the presence of IFNγ during
infection (Fig. 6d, h). As a measure of viral load, we also
quantified levels of MV protein using a polyclonal hu-
man antiserum (Fig. 7a). MV protein expression in-
creased over the course of infection, with no significant
difference in viral protein levels detected between geno-
types (Fig. 7b). Thus, the differences we observed in
levels of neural expression markers are not likely to be
due to variances in viral load between the genotypes.
Together, these results provide a secondary measure of
cell protein content and validate the flow cytometry re-
sults within a neurogenic region of the brain that con-
sistently carries a high viral load.
STAT1 phosphorylation in the hippocampus occurs
independently of IFNγ during MV infection
Since IFNγ affected neural cell marker expression in the
hippocampus (Fig. 6) and the whole brain (Fig. 2; NSPC
and neuron loss), we evaluated which IFN-signaling
pathways are activated in the hippocampus during a viral
infection. Type I interferons (IFNα and IFNβ) activate
STAT1 and STAT2 proteins via phosphorylation and are
required for early control of a viral infection. IFNγ, a
Type II interferon, predominately activates STAT1, but
can also activate STAT3 in neurons [56] and NSPCs
[57]. In particular, IFNγ is required for long-term con-
trol of neurotropic viruses in CD46+ adult mice and
other infection models [22, 58]. Thus, we analyzed hip-
pocampal explants for expression of STAT1-3 and acti-
vation of the STAT proteins via phosphorylation.
Hippocampal tissue lysates were analyzed for total
(STAT) and phosphorylated (STAT-P) forms of STAT
proteins that are activated by IFNα/β (STAT1, STAT2)
and IFNγ (STAT1, STAT3) (Figs. 8 and 9). STAT1 is
expressed as two isoforms; STAT1α, which exhibits
DNA binding activity, and STAT1β, which lacks a DNA
binding domain and acts as negative regulator of
STAT1α. Each isoform of STAT1 was assayed independ-
ently in Fig. 8. Total STAT1 expression and STAT1
phosphorylation was unchanged at 3 dpi in both geno-
types. In CD46+ explants, STAT1α was significantly acti-
vated via phosphorylation above untreated controls at 7
and 10 dpi (Fig. 8b), whereas STAT1β was significantly
activated at 7 dpi (Fig. 8c) when normalized to GAPDH.
CD46+/IFNγ-KO explants also demonstrated activation
of STAT1α and STAT1β, with significant activation of
both isoforms at 10 dpi (Fig. 8g, h). Total levels of
STAT1 expression increased at later time points post-
infection in both genotypes. CD46+ explants showed sig-
nificantly more expression of total STAT1α and β at
a. b.
c.
d e f g
Fig. 5 MV infection induces extensive apoptosis, but does not alter nestin localization. CD46+ and CD46+/IFNγ-KO brains were assayed by TUNEL
(a–c) or immunohistochemistry for nestin and NeuN at 7 dpi (d–g). The average TUNEL+ cells per field (four fields per slice) were averaged from
three different sagittal sections per mouse (c; n = 3 mice per condition). Significant increases in TUNEL+ cells were seen during infection in both
genotypes, but no significant difference was observed between genotypes (c; *p < 0.01 significantly different uninfected versus MV-infected).
Nestin (red) and NeuN (green) staining was observed in the hippocampus at 7 dpi in both CD46+ (d, e) and CD46+/IFNγ-KO (f, g) mice during
infection (scale bar = 100 μm)
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both 7 and 10 dpi (Fig. 8d, e), while significantly higher
expression of total STAT1 was only observed at 10 dpi
in the absence of IFNγ (Fig. 8i, j). These results demon-
strate that phosphorylation of STAT1 occurs in hippo-
campal tissue in the absence of IFNγ during infection,
potentially through expression of Type I IFNs. Protein
ratios of STAT1-P/STAT1 revealed distinct regulation of
STAT1 phosphorylation between genotypes that was iso-
form dependent (Fig. 8f, g, m, n). CD46+ mice showed a
significant increase in the STAT1α-P/STAT1α ratio at 10
dpi, which was absent at all time points in the absence
of IFNγ. Moreover, STAT1β-P/STAT1β ratios declined
during infection in CD46+/IFNγ-KO explants, but not
CD46+ explants. These data suggest IFNγ drives an in-
crease in phosphorylation of the available STAT1α in the
cell, although increased expression of both STAT1 iso-
forms occurs independently of IFNγ.
We further explored the activation of other STAT mole-
cules (STAT2 and STAT3) that have been implicated as
alternative signaling pathways downstream of IFNγ [56, 59]
(Fig. 9). STAT2 phosphorylation is induced in CD46+ ex-
plants at 7 and 10 dpi by MV infection (Fig. 9b), whereas
significant phosphorylation of STAT2 was only seen at 7
dpi in CD46+/IFNγ-KO explants (Fig. 9c) when normalized
to GAPDH. Total expression of STAT2 did not change sig-
nificantly with infection in either genotype (Fig. 9d, e).
However, total STAT2 levels increased independently of in-
fection over time in CD46+ explants (Fig. 9d). Protein ra-
tios of STAT2-P/STAT2 revealed increased activation of
phosphorylation of STAT2 in CD46+ mice, with a trend to-
ward increased regulation in CD46+/IFNγ-KO mice (Fig. 9f,
g). In contrast, STAT3 activation did not increase with in-
fection (Fig. 9i, j, m, n). Total STAT3 expression increased
at 10 dpi in CD46+ explants, which was not observed in
the absence of IFNγ (Fig. 9i, j), suggesting either IFNγ or
other inflammatory cytokines that are induced by IFNγ
(e.g., IL-6) may lead to greater STAT3 expression [60]. To-
gether, these results demonstrate that activation of STAT
Fig. 6 Impact of MV infection on expression of NSPC, neuronal, and glial markers in the hippocampus. Whole tissue lysates of hippocampal
explants from CD46+ (a–d) and CD46+/IFNγ-KO (e–h) control and MV-infected mice were analyzed by Western Blots for Nestin (NSPC; a–e), DCX
(early neuron; b, f), βIII-tubulin (mature neuron; c, g) and GFAP (astrocyte; d, h) proteins. Integrated intensity values for each band, which are
proportional to the sum of the fluorescent signal (measured in pixels) enclosed by the region of interest, are normalized to GAPDH as a protein
loading control. Changes in nestin and DCX hippocampal protein expression correspond with changes in cell number observed for whole-brain
cell isolates. *p < 0.01 significantly different uninfected versus MV-infected; #p < 0.05 significantly different between dpi
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signaling molecules does not differ significantly early in in-
fection (3 dpi), but that STAT1 and STAT2 phosphoryl-
ation occurs later infection in CD46+ and CD46+/IFNγ-
KO explants. Thus, phosphorylation of STAT1 in the brain
parenchyma may be influenced by cytokines other than
IFNγ during MV infection.
Discussion
This is the first study to directly examine the bystander
effects of the anti-viral immune response on NSPC func-
tion in a model with neuron-restricted viral infection.
Restricted NSPC proliferation and cell loss have been re-
ported for various neurotropic viruses, but NSPCs were
targets for the virus in many of these models [15, 17,
61]. Thus, the contributions from either the virus or the
immune response to alterations in the NSPC pool are
still unclear. In the CD46+ mouse model, NSPCs are
spared from MV-infection. We found that NSPCs were
protected by IFNγ in MV-infected pups, whereas
significant immature neuron loss was observed in both
CD46+ and CD46+/IFNγ-KO pups. Mature neuron and
glial cell numbers were unaltered. The proliferative
index of the NSPC populations was unaffected while
neurogenesis only declined at 10 dpi, suggesting that cell
loss in both NSPC and early neuron populations is likely
due to cell death and not due to changes in cell fate.
In the absence of IFNγ, the NSPC pool declined sig-
nificantly at 7 and 10 dpi, with a trend toward lower
NSPC numbers at 3 dpi (Fig. 2). The earliest time point
that we examined (3 dpi) is associated with a negligible
number of T-cells in the brain but with notable natural
killer cell infiltration (P. Ganesan, unpublished observa-
tions). It is possible that IFNγ production by T-cells is
required to afford protection to the NSPC pool at later
time points in infection. We also noted a lack of an ef-
fect on NSPC proliferation (Fig. 4), which we speculate
is due to NSPCs remaining uninfected in our model.
NSPCs infected with murine cytomegalovirus (MCMV)
[17, 62], lymphocytic choriomeningitis virus (LCMV)
[63], Japanese encephalitis virus (JEV) [61], and herpes
simplex virus, type 1 (HSV-1) [15] display reduced pro-
liferation that is associated with viral infection and repli-
cation in NSPCs. Instead, in our model, we suspect that
the loss of uninfected NSPCs is due to cell death in the
CD46+/IFNγ-KO pups. If NSPCs were undergoing a
change in cell fate, we would have expected an increase
in the number of neurons or glia, but instead we ob-
served a reduced and unchanged cell number, respect-
ively (Figs. 2 and 3), suggesting that the NSPCs are not
being lost due to commitment to other cell types. Since
direct viral infection cannot account for NSPC loss in
our model system, one possibility is that the cytokine
milieu that is released in the absence of IFNγ is ultim-
ately detrimental to the cells. A similar phenomenon has
been characterized in models of antigen-induced arth-
ritis, where IFNγ-KO mice suffer greater disease severity
due to overexpression of IL-17 [64]. Additionally, an
outstanding question that remains is how the presence
of IFNγ leads to protection of the NSPC pool in CD46+
neonates. IFNγ treatment of NSPCs in vitro leads to de-
creased proliferation in the absence of other cytokines
[65], which implies that IFNγ does not afford protection
to NSPCs by increasing proliferation in our model. De-
fining the anti-viral cytokine profile in CD46+ and CD46
+/IFNγ-KO pups may provide insight into the milieu
that is required to maintain the NSPC pool during
infection.
In CD46+ pups, young neurons are more susceptible
to cell loss than mature neurons. Newly committed
neuronal cells were lost at all time points post-infection
in CD46+/IFNγ-KO pups and at 7 and 10 dpi in CD46+
pups (Fig. 2). The production of new neurons, as mea-
sured by BrdU incorporation in CD24+ cells, declined
Fig. 7 IFNγ does not reduce measles virus antigen in neonatal brain.
a. Lysates of brain tissue from CD46+ and CD46+/IFNγ-KO neonates
were analyzed by Western Blot for measles virus antigen. Control
and MV-infected neonatal hippocampal lysates were collected at 3,
7, and 10 days post-infection (dpi) and probed with human
polyclonal serum against MV and GAPDH as a loading control. b.
Quantitation of MV levels normalized to GAPDH for each treatment
condition in a. Statistical analysis was applied by two-way ANOVA
(n = 4; *p < 0.01)
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only at 10 dpi in both genotypes. Thus, a decrease in
neurogenesis cannot account for the loss of early neu-
rons at other time point during infection (3 and 7 dpi,
Fig. 4). One possibility is that early neurons are infected
by MV as they fully differentiate, since the cells will
begin to express NSE, and thus the human CD46
Fig. 8 STAT1α and STAT1β isoforms in the hippocampus are phosphorylated in the absence of IFNγ during a viral infection. Lysates of
hippocampal explants from CD46+ (a–g) and CD46+/IFNγ-KO (h–n) control and MV-infected mice were analyzed by western blot for
phosphorylated (activated) STAT1 (b, c, i, j), and total STAT1 (d, e, k, l) proteins. GAPDH was used as a protein loading control. Representative blots
are shown in a and b. Total levels of STAT1α (upper band; d, k) and STAT1β (lower band; e, l) were significantly increased in MV-infected
hippocampal explants from CD46+ pups (d, e) at 7 and 10 dpi and in CD46+/IFNγ-KO pups (k, l) at 10 dpi. Phosphorylation of STAT1α (STAT1α-P;
B, I) increased significantly in CD46+ explants at 7 and 10 dpi (b) and CD46+/IFNγ-KO explants at 10 dpi (I). Phosphorylation of STAT1β (c, j) was
increased in CD46+ explants at 7 dpi only (c) and in CD46+/IFNγ-KO explants and 7 and 10 dpi (j). Protein ratios of STAT1α-P/STAT1α showed
increased activation of phosphorylation of STAT1α-P at 10 dpi in CD46+ mice (f), but no activation in CD46+/IFNγ-KO mice (m). The protein ratios
of STAT1β-P/STAT1β showed decreased activation of phosphorylation during infection in CD46+/IFNγ-KO mice (n), but not in CD46+ mice (g).
Statistical analysis was applied by one-way ANOVA with multiple comparisons. (**p < 0.01, ***p < 0.001, ****p < 0.0001 significantly different
uninfected versus MV-infected; n = 4)
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transgene, as MAP2 and βIII tubulin are induced [66].
In support of this possibility, NSPCs infected with Borna
disease virus (BDV) and human immunodeficiency
virus-1 (HIV-1) are unaffected by the viral infection.
However, once cells are committed to the neuronal
lineage and enter a post-mitotic state, apoptotic cell loss
Fig. 9 STAT2, but not STAT3, is activated during MV infection in the neonatal hippocampus. Lysates of hippocampal explants from CD46+ (black
bars; b, d, f, I, k, m) and CD46+/IFNγ-KO (grey bars; c, e, g, j, l, n) control and MV-infected mice were analyzed by western blot for phosphorylated
(activated) STAT2 (STAT2-P; b, c), total STAT2 (d, e), STAT2-P/STAT2 (f, g), STAT3-P (i, j), total STAT3 (k, l), and STAT3-P/STAT3 (m, n). GAPDH was
used as a protein loading control. Representative blots are shown for STAT2 (a) and STAT3 (h). STAT2-P levels were significantly increased in MV-
infected hippocampal explants in CD46+ (b) and CD46+/IFNγ-KO (c) pups at 7 dpi, though STAT2 phosphorylation was sustained to 10 dpi in
CD46+ explants. Protein ratios of STAT2-P/STAT2 showed significantly increased activation of phosphorylation in CD46+ mice at 3 and 7 dpi (f).
STAT3 phosphorylation was not significantly induced under any condition (g, h, m, n). Levels of total STAT3 protein were increased with infection
at 10 dpi in CD46+ explants (i), but not in CD46+/IFNγ-KO explants (j). Statistical analysis was applied by one-way ANOVA with multiple
comparisons (*p < 0.05, ***p < 0.001, ****p < 0.0001 significantly different uninfected versus MV-infected; n = 4)
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is observed [16, 67]. This led us to also consider whether
the subset of immature neurons lost during infection
were actually MV-infected. We attempted to co-label
our neural cells for MV proteins (not shown) to deter-
mine if CD24+ and DCX+ cells were MV-infected. Un-
fortunately, we were unable to successfully label our cell
isolates for MV proteins by flow cytometry. Regardless,
neuronal death is a common pathological outcome of
viral infection [14]. It is likely that the reduction in neur-
onal cell number we observed was due to cell death and
not due to NSPCs adopting a non-neuronal (glial) fate.
Furthermore, adult CD46+ mice exhibit only limited
apoptosis as a result of MV infection, which corresponds
with successful viral control and survival, whereas a
higher number TUNEL+ cells and death occurs in MV-
infected CD46+ neonates at 7 dpi and beyond (Fig. 5;
[19, 50]). Though adult CD46+ mice are capable of me-
diating non-cytolytic clearance of MV from CNS neu-
rons, neonatal CD46+ mice cannot mediate non-
cytolytic clearance, as evidenced by persistent viral
spread and widespread apoptosis in the brain paren-
chyma, despite T-cell infiltration [19, 49, 50]. Differences
in non-cytolytic responses from neonatal and adult T-
cells are poorly understood. However, our findings imply
that the neonatal immune response not only fails to con-
trol MV, but may also contribute to a loss of early neu-
rons during MV infection. In support of this hypothesis,
in vitro results demonstrate that embryonic CD46+ neu-
rons are not killed by MV infection directly [68], sug-
gesting that other factors contribute to loss of early
neurons in vivo.
Western Blot analysis on hippocampal explants displayed
changes in protein expression levels that corresponded with
effects on cell number for nestin and DCX, but not for
βIII-tubulin or GFAP (Fig. 6). The percentage of mature
NeuN+ cells was not significantly different in MV-infected
explants compared to controls by flow cytometry (Fig. 2),
but a significant reduction in βIII-tubulin expression was
observed in MV-infected samples at 7 dpi. It is possible that
the virus exerted regional effects on neuron survival and
that hippocampal neurons were more susceptible to infec-
tion at 7 dpi compared to other neurons elsewhere in the
brain. Another possibility is that the effects on hippocampal
neurons may not have been detectable in whole-brain iso-
lates where neurons from the hippocampus are a small
fraction of the total number of neurons isolated. Alterna-
tively, Zimmer and colleagues observed that βIII-tubulin
expression is downregulated at the transcriptional level by
low doses of toxins, without frank cell death [69]. Thus, loss
of βIII-tubulin may be indicative of stress on the hippocam-
pal neurons in our model, but the stressor may not be suffi-
cient to cause cell death. For GFAP staining, flow
cytometry did not reveal significant changes in the number
of GFAP+ cells (Fig. 3c, g) or in the intensity of the GFAP
signal in whole-brain isolates (Fig. 3d, h). However, at 7 and
10 dpi, a trend toward an increased number of GFAP+ cells
and greater GFAP intensity was observed, though this
change was not significant. When we examined GFAP
levels by Western Blot analysis in hippocampal explants,
there was a increase in GFAP expression at 7 dpi in MV-
infected CD46+ mice compared to uninfected CD46+ mice
(Fig. 6d) which was not observed in the absence of IFNγ. A
possible explanation for the discrepancy in our data is that
the hippocampus supports a high viral load in the CD46+
model. Therefore, the astrocytes in the hippocampus would
be more likely to respond consistently to infected neurons,
thus making changes in GFAP more readily detectable in
this region.
Having observed that IFNγ is protective for NSPCs
(Fig. 1), we attempted to characterize which IFNγ-related
signaling pathways are active in infected brain tissue. We
also considered that Type I interferons (IFNα and IFNβ)
may be functioning as protective factors in the CD46+
pups. These IFNs also signal through STAT signaling
pathways that are known to function in various CNS path-
ologies [70]. Furthermore, STAT1 signaling is important
for viral control in adult CD46+ mice before 6 dpi, when
the innate immune response is active [58]. We observed
increased phosphorylation of STAT1 and STAT2, but not
STAT3, in the hippocampi of MV-infected pups (Figs. 8
and 9). We had predicted that STAT1 signaling would be
more pronounced in CD46+ pups, since the CD46
+/IFNγ-KO pups would not have IFNγ available to acti-
vate STAT1. STAT1 phosphorylation occurred in the ab-
sence of IFNγ during MV infection, with CD46+/IFNγ-
KO showing pronounced phosphorylation of both STAT1
isoforms when normalized to GAPDH versus uninfected
controls (Fig. 8i, j). However, protein ratios for STAT1α-P/
STAT1α showed that only CD46+ mice increased regula-
tion of phosphorylation during infection (Fig. 8f, m).
Moreover, STAT1β-P/STAT1β ratios revealed decreased
regulation of phosphorylation in the absence of IFNγ
(Fig. 8n). These results suggest that IFNγ drives both in-
creased phosphorylation of STAT1α, which is the tran-
scriptionally active form of STAT1, during infection.
Furthermore, although the relative level of phosphoryl-
ation of the dominant-negative isoform of STAT1
(STAT1β) increased in both genotypes (Fig. 8c, j), the
regulation of STAT1β-P phosphorylation declined in the
absence of IFNγ. One possibility is that other cytokines
(e.g., IFNα/β) contribute to STAT1 phosphorylation dur-
ing the anti-MV immune response, thus causing distinct
patterns of STAT1 phosphorylation between genotypes. In
CD46+ pups, STAT1 phosphorylation peaked at 7 dpi and
then declined by 10 dpi (Fig. 8b–e). STAT2 activation also
demonstrated a similar pattern to STAT1 (Fig. 9b), sug-
gesting that a subset of signaling events was declining to-
ward the end of the time course. Most of the CD46+ pups
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succumb to the infection between 9–12 dpi regardless of
IFNγ expression [49], and it is unclear why the CD46+
pups would demonstrate a decline in inflammatory signal-
ing pathways when the virus is still present. However, fu-
ture studies will examine the cytokine expression profile
over the course of infection in CD46+ pups, which may
provide an explanation as to the reduction in STAT1 and
STAT2 signaling by 10 dpi.
Viral infections in the brain induce microglial and
astrocytic activation, in addition to infiltration of periph-
eral immune cells. Widespread F4/80+ activated micro-
glial staining was reported in MV-infected NSE-CD46+
pups at 7 dpi [50], leaving open the possibility that the
effects we observed on NSPCs and immature neurons
were due to indirect effects on IFNγ-responsive micro-
glia during infection. Activated microglia release pro-
inflammatory factors that can positively or negatively
impact neuronal function [71–73]. For example, IFNγ-
activated microglia were shown to promote neurogenesis
from NSPCs and to promote neuronal survival in vitro
[74, 75]. In our study, the loss of IFNγ may have resulted
in reduced microglial activation that compromised
NSPC number in CD46+/IFNγ-KO mice but not CD46+
mice, due to a loss of protection or a loss of trophic sup-
port. We also observed a loss of immature neurons in
both CD46+ and CD46+/IFNγ-KO pups, suggesting that
IFNγ does not protect this population (Fig. 1). There-
fore, another possibility is that microglial activation is
detrimental to early neuron survival, independent of
IFNγ. Microglial activation has been shown to cause
neuronal apoptosis in the cortex, cerebellum, and hippo-
campus of BDV-infected neonatal rats in vivo [76, 77].
In our model, subpopulations of microglia may be more
or less reliant on IFNγ for activation and in our model
this may have contributed to protection over NSPCs,
but not early neurons, respectively.
Our studies are focused on the role of IFNγ in viral
pathogenesis in the CNS. However, IFNγ is also expressed
in many neurodegenerative disease states [78–80] where
alterations in NSPC function are also observed. Though
the pathology of these disease states varies, an under-
standing of the contribution of key cytokines, as well as
combinations of multiple inflammatory mediators, will be
necessary to fully understand the impact of the immune
response on NSPC activity and survival.
Conclusions
This is the first study to demonstrate that IFNγ protects
NSPCs during a CNS viral infection. A transgenic mouse
model of neuron-restricted MV infection was used to
test the effects of the inflammatory environment created
by the anti-viral immune response on NSPCs. Our re-
sults are the first to directly show that anti-viral immun-
ity imposes bystander effects that compromise NSPC
cell number, in the absence of IFNγ. It is still unclear
what component of the immune response is damaging
to NSPC function. Recent work by Hu and colleagues
indicated that activated CD8+ T-cells, but CD4+ T-cells,
reduced proliferation of MHC-matched NSPCs through
the release of IFNγ in vitro [81]. While we did not ob-
serve a decline in NSPC proliferation in our in vivo
model, these results highlight the importance of consid-
ering the roles of specific immune cells in affecting
NSPC function. It will be interesting to identify the im-
mune cell subsets that are present during the 3–10 dpi
window in order to clarify which immune cell popula-
tion compromises NSPC and early neuron cell number.
Overall, this study implicates IFNγ as one cytokine in-
volved in preserving NSPCs during viral infections and
other inflammatory conditions.
Additional file
Additional file 1: Figure S1. Representative flow cytometry plots for
neural cell identification. Brain homogenates from neonatal mice were
analyzed via flow cytometry. Representative plots for each IgG isotype
control and the respective neural cell antibody are shown. Top row:
Forward/side scatter and 7-AAD negative (−) gates were applied to all
samples. 2nd row: Markers for neural stem cells (nestin) and early
neuronal markers (doublecortin, DCX). 3rd row: Markers for early neurons
(CD24) and for mature neurons (NeuN). 4th Row: Markers for early glial
progenitors (A2B5) and mature astrocytes (GFAP). (PDF 504 kb)
Abbreviations
ANOVA: Analysis of variance; ATCC: American Type Tissue Collection;
BDV: Borna disease virus; BrdU: 5-bromo-2′-deoxyuridine; CNS: Central
nervous system; Dpi: Day post-infection; DCX: Doublecortin;
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; GFAP: Glial fibrillary
acidic protein; HIV-1: Human immunodeficiency virus-1; KO: Knockout; HSV-
1: Herpes simplex virus, type 1; IFN: Interferon; IFNα: Interferon-alpha;
IFNβ: Interferon-beta; IFNγ: Interferon-gamma; JEV: Japanese encephalitis
virus; LCMV: Lymphocytic choriomeningitis virus; MAP2: Microtubule
associated protein 2; MFI: Mean fluorescent intensity; MV: Measles virus;
MCMV: Murine cytomegalovirus; MHC: Major histocompatibility complex;
NSE: Neuron-specific enolase; NSPC: Neural stem/precursor cell; P: Postnatal
day; PBS/tw: Phosphate-buffered saline and Tween-20; PFU: Plaque forming
unit; SE: Standard error; STAT: Signaling transducer and activator of
transcription; STAT-P: Phosphorylated signaling transducer and activator of
transcription; TUNEL: Terminal deoxynucleotidyl transferase dUTP nick end
labeling.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KNF and LOD conceived and designed the study and wrote the paper. KNF,
ELG, PG, and AK performed the experiments. KNF, ELG, PG, and AK analyzed
the data. All authors read and approved the final manuscript.
Acknowledgements
We are very grateful to Glenn Rall (Fox Chase Cancer Center) for providing
the CD46+ and CD46+/IFNγ-KO mice. We thank Manohar Mutnal (University
of Minnesota) for advice with flow cytometry experiments, David Lee (BD
Biosciences) for help with flow cytometry gating and BrdU analysis, and
Jessica Posimo and Amanda Gleixner for technical advice with western blots.
This research was funded by the Hunkele Dreaded Disease Award (LOD), the
Samuel and Emma Winters Foundation (LOD), the Duquesne University
Mylan School of Pharmacy (KNF, LOD), and R15-NS087606-01A1 (LOD).
Fantetti et al. Journal of Neuroinflammation  (2016) 13:107 Page 15 of 17
Received: 2 October 2015 Accepted: 6 May 2016
References
1. Schleede L, Bueter W, Baumgartner-Sigl S, Opladen T, Weigt-Usinger K, Stephan S,
Smitka M, Leiz S, Kaiser O, Kraus V. Pediatric herpes simplex virus encephalitis: a
retrospective multicenter experience. J Child Neurol. 2013;28:321–31.
2. Bonthius DJ. Lymphocytic choriomeningitis virus: a prenatal and postnatal
threat. Adv Pediatr. 2009;56:75–86.
3. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ. HIV-1-related
encephalopathy in infants compared with children and adults. French Pediatric
HIV Infection Study and the SEROCO Group. Neurology. 2000;54:1089–95.
4. Douvoyiannis M, Litman N, Goldman DL. Neurologic manifestations associated
with parvovirus B19 infection. Clin Infect Dis. 2009;48:1713–23.
5. Allsopp TE, Scallan MF, Williams A, Fazakerley JK. Virus infection induces
neuronal apoptosis: a comparison with trophic factor withdrawal. Cell Death
Differ. 1998;5:50–9.
6. Denizot M, Neal JW, Gasque P. Encephalitis due to emerging viruses: CNS
innate immunity and potential therapeutic targets. J Infect. 2012;65:1–16.
7. Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B.
Poliovirus induces apoptosis in the mouse central nervous system. J Virol.
1999;73:6066–72.
8. Kaul M, Lipton SA. Experimental and potential future therapeutic approaches
for HIV-1 associated dementia targeting receptors for chemokines, glutamate
and erythropoietin. Neurotox Res. 2005;8:167–86.
9. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. HIV-1 infection and
AIDS: consequences for the central nervous system. Cell Death Differ. 2005;
12 Suppl 1:878–92.
10. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM,
Knipe DM, Finberg RW. Herpes simplex virus 1 interaction with Toll-like receptor
2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A. 2004;101:1315–20.
11. Lyman M, Lloyd DG, Ji X, Vizcaychipi MP, Ma D. Neuroinflammation: the role
and consequences. Neurosci Res. 2014;79:1–12.
12. Mutnal MB, Hu S, Little MR, Lokensgard JR. Memory T cells persisting in the
brain following MCMV infection induce long-term microglial activation via
interferon-gamma. J Neurovirol. 2011;17:424–37.
13. McKay R. Stem cells in the central nervous system. Science. 1997;276:66–71.
14. Das S, Basu A. Viral infection and neural stem/progenitor cell's fate:
Implications in brain development and neurological disorders. Neurochem
Int. 2011;59:357–66.
15. Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ.
Microglia-induced IL-6 protects against neuronal loss following HSV-1
infection of neural progenitor cells. Glia. 2014;62:1418–34.
16. Brnic D, Stevanovic V, Cochet M, Agier C, Richardson J, Montero-Menei CN,
Milhavet O, Eloit M, Coulpier M. Borna disease virus infects human neural
progenitor cells and impairs neurogenesis. J Virol. 2012;86:2512–22.
17. Mutnal MB, Cheeran MC, Hu S, Lokensgard JR. Murine cytomegalovirus
infection of neural stem cells alters neurogenesis in the developing brain.
PLoS One. 2011;6, e16211.
18. Ruller CM, Tabor-Godwin JM, Van Deren Jr DA, Robinson SM, Maciejewski S,
Gluhm S, Gilbert PE, An N, Gude NA, Sussman MA. Neural stem cell
depletion and CNS developmental defects after enteroviral infection. Am J
Pathol. 2012;180:1107–20.
19. Patterson CE, Lawrence DM, Echols LA, Rall GF. Immune-mediated
protection from measles virus-induced central nervous system disease is
noncytolytic and gamma interferon dependent. J Virol. 2002;76:4497–506.
20. Finke D, Brinckmann UG, ter Meulen V, Liebert UG. Gamma interferon is a
major mediator of antiviral defense in experimental measles virus-induced
encephalitis. J Virol. 1995;69:5469–74.
21. Stubblefield Park SR, Widness M, Levine AD, Patterson CE. T cell-, interleukin-
12-, and gamma interferon-driven viral clearance in measles virus-infected
brain tissue. J Virol. 2011;85:3664–76.
22. Binder GK, Griffin DE. Interferon-gamma-mediated site-specific clearance of
alphavirus from CNS neurons. Science. 2001;293:303–6.
23. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA.
IFN-gamma is required for viral clearance from central nervous system
oligodendroglia. J Immunol. 1999;162:1641–7.
24. Hausmann J, Pagenstecher A, Baur K, Richter K, Rziha HJ, Staeheli P. CD8 T
cells require gamma interferon to clear borna disease virus from the brain
and prevent immune system-mediated neuronal damage. J Virol. 2005;79:
13509–18.
25. Richter K, Hausmann J, Staeheli P. Interferon-gamma prevents death of
bystander neurons during CD8 T cell responses in the brain. Am J Pathol.
2009;174:1799–807.
26. Geiger KD, Nash TC, Sawyer S, Krahl T, Patstone G, Reed JC, Krajewski S, Dalton D,
Buchmeier MJ, Sarvetnick N. Interferon-gamma protects against herpes simplex
virus type 1-mediated neuronal death. Virology. 1997;238:189–97.
27. Yoneyama M, Shiba T, Hasebe S, Ogita K. Adult neurogenesis is regulated
by endogenous factors produced during neurodegeneration. J Pharmacol
Sci. 2011;115:425–32.
28. Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis:
the dual role of microglia. Neuroscience. 2009;158:1021–9.
29. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging
pathogens. Lancet. 2002;359:507–13.
30. Baron R, Nemirovsky A, Harpaz I, Cohen H, Owens T, Monsonego A. IFN-
gamma enhances neurogenesis in wild-type mice and in a mouse model of
Alzheimer’s disease. FASEB J. 2008;22:2843–52.
31. Johansson S, Price J, Modo M. Effect of inflammatory cytokines on major
histocompatibility complex expression and differentiation of human neural
stem/progenitor cells. Stem Cells. 2008;26:2444–54.
32. Barish ME, Mansdorf NB, Raissdana SS. Gamma-interferon promotes
differentiation of cultured cortical and hippocampal neurons. Dev Biol. 1991;
144:412–23.
33. LaFerla FM, Sugarman MC, Lane TE, Leissring MA. Regional hypomyelination
and dysplasia in transgenic mice with astrocyte-directed expression of
interferon-gamma. J Mol Neurosci. 2000;15:45–59.
34. Kim IJ, Beck HN, Lein PJ, Higgins D. Interferon gamma induces retrograde
dendritic retraction and inhibits synapse formation. J Neurosci. 2002;22:4530–9.
35. Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, Grigoriadis
N. Effects of proinflammatory cytokines on the growth, fate, and motility of
multipotential neural precursor cells. Mol Cell Neurosci. 2003;24:623–31.
36. Walter J, Honsek SD, Illes S, Wellen JM, Hartung HP, Rose CR, Dihne M. A
new role for interferon gamma in neural stem/precursor cell dysregulation.
Mol Neurodegener. 2011;6:18.
37. Wong G, Goldshmit Y, Turnley AM. Interferon-gamma but not TNF alpha
promotes neuronal differentiation and neurite outgrowth of murine adult
neural stem cells. Exp Neurol. 2004;187:171–7.
38. O’Donnell LA, Henkins KM, Kulkarni A, Matullo CM, Balachandran S,
Pattisapu AK, Rall GF. Interferon gamma induces protective non-canonical
signaling pathways in primary neurons. J Neurochem. 2015;135(2):309-322.
39. Tirotta E, Kirby LA, Hatch MN, Lane TE. IFN-gamma-induced apoptosis of
human embryonic stem cell derived oligodendrocyte progenitor cells is
restricted by CXCR2 signaling. Stem Cell Res. 2012;9:208–17.
40. Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MB. A
transgenic mouse model for measles virus infection of the brain. Proc Natl
Acad Sci U S A. 1997;94:4659–63.
41. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells
of the adult mammalian central nervous system. Science. 1992;255:1707–10.
42. Panchision DM, Chen HL, Pistollato F, Papini D, Ni HT, Hawley TS. Optimized
flow cytometric analysis of central nervous system tissue reveals novel
functional relationships among cells expressing CD133, CD15, and CD24.
Stem Cells. 2007;25:1560–70.
43. Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV. Dead cell
discrimination with 7-amino-actinomycin D in combination with dual color
immunofluorescence in single laser flow cytometry. Cytometry. 1992;13:204–8.
44. Bilsland JG, Haldon C, Goddard J, Oliver K, Murray F, Wheeldon A,
Cumberbatch J, McAllister G, Munoz-Sanjuan I. A rapid method for the
quantification of mouse hippocampal neurogenesis in vivo by flow
cytometry. Validation with conventional and enhanced
immunohistochemical methods. J Neurosci Methods. 2006;157:54–63.
45. Posimo JM, Titler AM, Choi HJ, Unnithan AS, Leak RK. Neocortex and
allocortex respond differentially to cellular stress in vitro and aging in vivo.
PLoS One. 2013;8, e58596.
46. Gleixner AM, Pulugulla SH, Pant DB, Posimo JM, Crum TS, Leak RK. Impact of
aging on heat shock protein expression in the substantia nigra and striatum
of the female rat. Cell Tissue Res. 2014;357(1):43-54.
47. Leak RK, Castro SL, Jaumotte JD, Smith AD, Zigmond MJ. Assaying multiple
biochemical variables from the same tissue sample. J Neurosci Methods.
2010;191:234–8.
48. Hagihara H, Toyama K, Yamasaki N, Miyakawa T. Dissection of
hippocampal dentate gyrus from adult mouse. J Vis Exp. 2009;(33),
e1543. doi:10.3791/1543.
Fantetti et al. Journal of Neuroinflammation  (2016) 13:107 Page 16 of 17
49. Lawrence DM, Vaughn MM, Belman AR, Cole JS, Rall GF. Immune response-
mediated protection of adult but not neonatal mice from neuron-restricted
measles virus infection and central nervous system disease. J Virol. 1999;73:
1795–801.
50. Manchester M, Eto DS, Oldstone MB. Characterization of the inflammatory
response during acute measles encephalitis in NSE-CD46 transgenic mice.
J Neuroimmunol. 1999;96:207–17.
51. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol. 1999;
57:563–81.
52. Li L, Walker TL, Zhang Y, Mackay EW, Bartlett PF. Endogenous interferon
gamma directly regulates neural precursors in the non-inflammatory brain.
J Neurosci. 2010;30:9038–50.
53. Wang J, Lin W, Popko B, Campbell IL. Inducible production of interferon-
gamma in the developing brain causes cerebellar dysplasia with activation
of the Sonic hedgehog pathway. Mol Cell Neurosci. 2004;27:489–96.
54. Kim SJ, Son TG, Kim K, Park HR, Mattson MP, Lee J. Interferon-gamma
promotes differentiation of neural progenitor cells via the JNK pathway.
Neurochem Res. 2007;32:1399–406.
55. Lum M, Croze E, Wagner C, McLenachan S, Mitrovic B, Turnley AM.
Inhibition of neurosphere proliferation by IFNgamma but not IFNbeta is
coupled to neuronal differentiation. J Neuroimmunol. 2009;206:32–8.
56. Cheng X, Jin G, Zhang X, Tian M, Zou L. Stage-dependent STAT3 activation
is involved in the differentiation of rat hippocampus neural stem cells.
Neurosci Lett. 2011;493:18–23.
57. Zhang SS, Liu MG, Kano A, Zhang C, Fu XY, Barnstable CJ. STAT3 activation
in response to growth factors or cytokines participates in retina precursor
proliferation. Exp Eye Res. 2005;81:103–15.
58. O’Donnell LA, Conway S, Rose RW, Nicolas E, Slifker M, Balachandran S, Rall
GF. STAT1-independent control of a neurotropic measles virus challenge in
primary neurons and infected mice. J Immunol. 2012;188:1915–23.
59. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S,
Koszinowski U, Hengel H.
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma}
signaling and antiviral responses. J Exp Med. 2005;201:1543–53.
60. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human
interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in
monocytic cells involves cooperation between interferon regulatory factor-1,
NF kappa B, and Sp1 transcription factors. J Biol Chem. 1995;270:27920–31.
61. Das S, Basu A. Japanese encephalitis virus infects neural progenitor cells and
decreases their proliferation. J Neurochem. 2008;106:1624–36.
62. Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y.
Cytomegalovirus infection of the central nervous system stem cells from
mouse embryo: a model for developmental brain disorders induced by
cytomegalovirus. Lab Invest. 2000;80:1373–83.
63. Sharma A, Valadi N, Miller AH, Pearce BD. Neonatal viral infection decreases
neuronal progenitors and impairs adult neurogenesis in the hippocampus.
Neurobiol Dis. 2002;11:246–56.
64. Irmler IM, Gajda M, Brauer R. Exacerbation of antigen-induced arthritis in
IFN-gamma-deficient mice as a result of unrestricted IL-17 response.
J Immunol. 2007;179:6228–36.
65. Makela J, Koivuniemi R, Korhonen L, Lindholm D. Interferon-gamma
produced by microglia and the neuropeptide PACAP have opposite effects
on the viability of neural progenitor cells. PLoS One. 2010;5, e11091.
66. Oh J, You Y, Yun Y, Lee HL, Yoon do H, Lee M, et al.
67. McCarthy M, Vidaurre I, Geffin R. Maturing neurons are selectively sensitive
to human immunodeficiency virus type 1 exposure in differentiating human
neuroepithelial progenitor cell cultures. J Neurovirol. 2006;12:333–48.
68. Lawrence DM, Patterson CE, Gales TL, D’Orazio JL, Vaughn MM, Rall GF. Measles
virus spread between neurons requires cell contact but not CD46 expression,
syncytium formation, or extracellular virus production. J Virol. 2000;74:1908–18.
69. Zimmer B, Schildknecht S, Kuegler PB, Tanavde V, Kadereit S, Leist M.
Sensitivity of dopaminergic neuron differentiation from stem cells to
chronic low-dose methylmercury exposure. Toxicol Sci. 2011;121:357–67.
70. Campbell IL. Cytokine-mediated inflammation, tumorigenesis, and disease-
associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res Brain Res
Rev. 2005;48:166–77.
71. Das S, Basu A. Inflammation: a new candidate in modulating adult
neurogenesis. J Neurosci Res. 2008;86:1199–208.
72. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is
detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A. 2003;
100:13632–7.
73. Vallieres L, Campbell IL, Gage FH, Sawchenko PE. Reduced hippocampal
neurogenesis in adult transgenic mice with chronic astrocytic production of
interleukin-6. J Neurosci. 2002;22:486–92.
74. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M. Activation of microglia
by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II
expression and renders them cytotoxic whereas IFN-gamma and IL-4 render
them protective. Mol Cell Neurosci. 2005;29:381–93.
75. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, Martino G,
Schwartz M. Microglia activated by IL-4 or IFN-gamma differentially induce
neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol
Cell Neurosci. 2006;31:149–60.
76. Weissenbock H, Hornig M, Hickey WF, Lipkin WI. Microglial activation and
neuronal apoptosis in Bornavirus infected neonatal Lewis rats. Brain Pathol.
2000;10:260–72.
77. Ovanesov MV, Moldovan K, Smith K, Vogel MW, Pletnikov MV. Persistent
Borna Disease Virus (BDV) infection activates microglia prior to a detectable
loss of granule cells in the hippocampus. J Neuroinflammation. 2008;5:16.
78. Mastrangelo MA, Sudol KL, Narrow WC, Bowers WJ. Interferon-{gamma}
differentially affects Alzheimer’s disease pathologies and induces
neurogenesis in triple transgenic-AD mice. Am J Pathol. 2009;175:2076–88.
79. Barcia C, Ros CM, Annese V, Gomez A, Ros-Bernal F, Aguado-Yera D,
Martinez-Pagan ME, de Pablos V, Fernandez-Villalba E, Herrero MT. IFN-
gamma signaling, with the synergistic contribution of TNF-alpha, mediates
cell specific microglial and astroglial activation in experimental models of
Parkinson’s disease. Cell Death Dis. 2011;2, e142.
80. Seifert HA, Collier LA, Chapman CB, Benkovic SA, Willing AE, Pennypacker KR.
Pro-inflammatory interferon gamma signaling is directly associated with stroke
induced neurodegeneration. J Neuroimmune Pharmacol. 2014;9:679–89.
81. Hu S, Rotschafer JH, Lokensgard JR, Cheeran MC. Activated CD8+ T
lymphocytes inhibit neural stem/progenitor cell proliferation: role of
interferon-gamma. PLoS One. 2014;9, e105219.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Fantetti et al. Journal of Neuroinflammation  (2016) 13:107 Page 17 of 17
